efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine gree fluorescence guidance

efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine gree fluorescence guidance - efficacy of sentinel node biopsy in oral cancer using 3D-CT lymphography and an indocyanine gree fluorescence guidance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024924

Enrollment

Registered

2016-11-22

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral cancer

Interventions

We perfomethe sentinel lymph node biopsy in oral cancer patients using 3D-CT lymphography and ICG fluorescence guidance

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with previously untreated cTxN0M0 oral cancer who was evaluated with clinical examination,ulutrasound,CT,and or MRI,are the canditates for our study. patient no having in history of previous head and neck cancer, no allergy to iodne,shelfish and ICG

Exclusion criteria

Exclusion criteria: A history of radiation therapy to neck,prior head and neck cancer Pregnacy or lactating women ,or women with suspected pregnancy

Design outcomes

Primary

Measure	Time frame
Identification rate of sentinel lymph node by using 3D-CT lymphography and ICG fluorescence guidance	—

Secondary

Measure	Time frame
1.False negative rate of sentinel lymph node 2.Relations between BMI and identification rate of sentinel lymph node	—

Countries

Japan

Contacts

Public ContactOsamu Ishihara

Osaka General Medical Center Oral & Maxillofacial Surgery

ishihara@gh.opho.jp06-6692-1201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026